SLE patients display high expression of IFN-stimulated genes (ISGs) called the IFN signature10, and animal experiments have revealed that blocking of type I IFN signaling inhibits SLE-like symptoms11–13. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.